论文部分内容阅读
目的评价宫术安栓作为人流手术的术前镇痛用药的临床效果和安全性。方法将12460例人流受术者分为用药组(9850例)和未用药组(2610例),进行疗效对比研究。疗效指标包括疼痛程度、宫颈松弛度、手术时间和人流综合症发生率及药物副作用。结果用药组较未用药组,术中疼痛程度明显减轻,宫颈松弛度显著增加,手术操作时间略有缩短,人流综合症发生率明显减少,未发现明显的与药物相关的副作用。结论宫术安栓是一种理想的人流手术镇痛用药;给药途经方便,临床疗效显著;可减轻疼痛、松弛宫颈、加快手术、降低手术并发症,且无明显毒副作用;建议推广应用。
Objective To evaluate the clinical effect and safety of Gongshizhuan suppository as a preoperative analgesic for abortion. Methods A total of 12,460 people who were admitted to our hospital were divided into medication group (9850 cases) and non-medication group (2610 cases). Efficacy indicators include the degree of pain, cervical relaxation, operation time and the incidence of flow syndrome and drug side effects. Results Compared with the untreated group, the degree of intraoperative pain was significantly reduced, the degree of cervical relaxation was significantly increased, the operation time was shortened, and the incidence of human flow syndrome was significantly reduced. No obvious drug-related side effects were found. Conclusion Gongshizhuan suppository is an ideal abortion analgesic for human abortion. It has convenient administration and clinical curative effect. It can relieve pain, relax the cervix, speed up the operation and reduce the complications of operation, and has no obvious side effects. It is recommended to popularize and apply.